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ABSTRACT 
Implanting Loop Recorders in a Hospital Unit versus the Electrophysiology 
Laboratory: A Retrospective Chart Review 
Marie-Paule M. Lafontant, EdD/CI, MSN, RN-BC; Valerie E. Smith, MSN, RN, MSHSA;   
Nohemi Sadule-Rios, PhD, APRN; Marsha Camille Lambert, MSN, APRN, RN-BC 
Introduction: Cardiac arrhythmias and unexplained syncopal episodes remain a challenge for clinicians to diag-
nose.  The recent creation of the smallest Implantable Loop Recorder (ILR) assists in identifying the causes behind 
cardiac and neurological events.  The current study aimed to compare the practice of implanting loop recorders at 
the bedside in the Cardiac and Vascular Care Unit (CVCU) to implantations in the Electrophysiology Laboratory 
(EP Lab).  
Methods: This study was a retrospective review of electronic medical records.  Data abstraction included 
implantation dates, time of admission and discharge, length of stay (LOS), number of healthcare staff involved, 
and cost of the procedure.  
Results: Over  ten months, 63 ILRs were implanted in the EP Lab and 131 ILRs at the bedside.  Patients 
LOS, on average, in the EP Lab was five hours versus four hours at the bedside.  Five staff were required to im-
plant the ILR in the EP Lab, and two at the bedside.  Based on 63 cases in the EP Lab, the hospital generated reve-
nue of $395,640, whereas the 131 cases at the bedside generated revenue of $822,680.  This resulted in an increase 
in revenue of $427,040.  
Discussion: A higher  number  of procedures were done at the bedside leading to a decreased average length 
of stay, number of staff involved, cost of the procedure, and a reduction in waiting time for patient admission and 
discharge.  
Keywords: Bedside, Cardiac and Vascular  Care Unit, Costs, Electrophysiology laboratory, Implantable 
loop recorder 
INTRODUCTION 
Cardiac arrhythmias, unexplained syncopal epi-
sodes, and cryptogenic stroke remain a challenge for 
clinicians to diagnose (Olsen, Biering-Sørensen, & 
Krieger, 2015).  Early diagnostic methods failed to 
detect these isolated incidents when occurring unex-
pectedly (Shanmugam & Liew, 2012).  Cardiac moni-
toring, a tool to counteract this challenge shifted from 
the traditional 12 lead electrocardiographs in-patient 
monitoring to Holter device monitoring. The introduc-
tion of the implantable loop recorders (ILRs) was a 
turning point in arrhythmia management (Olsen et al., 
2015).   
The first ILRs were developed in the 1980s 
(Tomson & Passman, 2015). They are used in the long 
term monitoring of patients with arrhythmias (Mittal et 
al., 2015).  Patients who suffered an unexplained syn-
copal episode would benefit from the insertion of an 
ILR as a first step in diagnosing the need for a perma-
nent pacemaker implantation (Sheldon, 2013).  
Until the early 2000s, these devices were implant-
ed in the electrophysiology laboratory (EP Lab) or the 
operating room (OR). Krahn, Klein, Yee, and Skanes 
(2004) indicated that this procedure was completed by 
cardiac surgeons or interventional cardiologists. They 
further compared the process of implantation to a pace-
maker insertion. Under anesthesia, physicians created a 
pocket to lodge the sizeable device (Grubb, Welch, 
Kanj-wal, Karabin, & Kanjwal, 2010).  The procedure 
done under sedation lasted for 20-30 minutes (Mofrad, 
2012, p. e473). In the 21st Century, experts in the field 
designed the smallest existing loop recorders (Tomson 
& Passman, 2015).  The newest implantable loop re-
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corders (ILRs) are “87% smaller than their predeces-
sor” (Pürerfellner, Sanders, Pokushalov, Di Bacco, 
Bergemann, & Dekker, 2015, p.1114).  Implantable 
loop recorders are inserted subcutaneously during a 
minimally invasive procedure according to manufac-
turer’s recommendations (Maines et al., 2018).    
A literature review revealed information on the 
implantation of ILRs in the EP Lab, the OR, with few 
implants inserted outside the hospital settings 
(Pachulski et al., 2013; Krahn et al., 2004; Yee & 
Skanes, 2004). Some studies exist on implanting ILRs 
outside the EP Lab and the OR (Pachulski, Cockrell, 
Solomon, Yang, & Rogers, 2013; Pürerfellner et al., 
2015).  Hospital leaders began investigating the possi-
bility of implanting ILRs in another hospital setting.  
Wong et al. (2016) evaluated the effects on patients 
with ILRs implanted in the EP Lab versus in a sterile 
room and found no significant differences in patient 
outcomes.  Maines et al. (2018), Miracapillo et al. 
(2016) concluded that inserting an ILR is a simple, 
safe, and quick procedure.   
Implantable loop recorders help in the establish-
ment of more precise cardiac diagnosing by monitor-
ing patients’ symptoms long term out of the hospital 
(Cvetković et al., 2016; Olsen et al., 2015).  ILRs al-
low the patients to become more engaged in their own 
care and aware of their health status (Olsen et al., 
2015). ILRs longer battery life, the ability to monitor 
patients 24/7, and ease of insertion gives the electro-
physiologists the option to perform implants outside of 
the EP Lab or OR (Gunda et al., 2015).   
Little is known about the advantages of implanting 
the device at the bedside in an outpatient unit.  The use 
of a descriptive retrospective chart review, in a Mag-
net® hospital, located in South Florida, provided addi-
tional information which helped fill the existing gap in 
the current literature.  The research hypothesis was that 
implantation of ILRs at the bedside would result in 
cost savings, decreased length of stay (LOS), and an 
increase in hospitals’ return on investment (ROI).   
METHODS 
Study Design and Sample 
This retrospective chart review included a conven-
ience sample of medical charts.  A total of N=194 elec-
tronic medical charts were reviewed from January 1, 
2015, to January 29, 2016.  Sixty-three charts from 
patients who had ILRs implanted in the EP Lab and 
131 from patients with ILRs implanted at the bedside 
in the Cardiac Vascular Care Unit (CVCU) met the 
inclusion criteria. ILRs implanted in the OR and pa-
tients scheduled for multiple procedures were exclud-
ed. The same EP technician was used for all implanta-
tions.  The research team reviewed the data to identify 
whether there were differences in patients’ LOS, dura-
tion of the procedure, hospital costs, and use of staff 
resources when implanting ILRs in CVCU versus the 
EP Lab.  The research team also examined if there 
would be an increase in the number of procedures 
based on procedure setting (EP Lab vs. bedside) possi-
bly increasing the hospital’s ROI, which could affect 
the decision of hospital administrators in their choice 
of implant setting.                               .                       
Data Collection/Analysis 
A data abstraction tool was developed to include 
implantation dates, time of patient admission and dis-
charge, LOS, number of healthcare staff involved, and 
cost per procedure.  Data were recorded in a manner to 
protect subjects’ identification with no possible link to 
the subjects.  Investigators were trained on how to col-
lect the data prior to conducting the study to ensure 
standardization and consistency of the process.  Data 
analysis was performed using the Statistical Package 
for Social Sciences (SPSS) version 24.  
Ethical Considerations  
This study received approval from the hospital 
Institutional Review Board (IRB).   
RESULTS 
The results from this study revealed that the aver-
age length of stay (LOS) from admission to discharge 
for patients in the EP Lab was five hours or 295 
minutes (M=294.84, SD= 106.9) and four hours or 
221 minutes (M= 221.43, SD= 104.08) for patients in 
CVCU. Furthermore, fewer staff were required (n = 2, 
M=2.02, SD=.26) to do the procedure in CVCU than 
in the EP Lab (n=5, M=4.73, SD=.91).  Over ten 
months, 63 ILRs were done in the EP Lab compared to 
131 in CVCU (Table 1).   
Cost-related Results:   
The number of staff required to implant the ILR in 
the EP Lab was five full-time employees: one CVCU 
RN, two EP RNs, and two EP technicians.  Bedside 
procedure for ILR included two staff: one CVCU RN 
Table 1 
 
Loop Recorders in EP Lab vs CVCU   
Procedure 
Setting 
Months Patients 
Length of Stay (minutes) 
Mean (SD) 
Staff per  
Procedure 
Staff 
Mean (SD) 
Length of Stay 
(hours) 
EP Lab 10 63 294.84 (106.9) 5 4.73(.91) 5 
CVCU 10 131 221.43 (104.08) 2 2.02 (.26) 4 
Note. EP: Electrophysiology, CVCU: Cardiac and Vascular Unit, SD: standard deviation 
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and one EP technician. CVCU RN average hourly sal-
ary was $45.00 at the bedside and $51.36 in the EP 
Lab. The EP technician hourly salary average was 
$39.08 for both bedside procedure and EP Lab (Table 
2). The cost to perform the ILR procedure in the EP 
Lab was more than the cost to perform the same proce-
dure in CVCU. Table 3 shows the labor charges bro-
ken down into 15-minute increments.  
The total labor cost per hour to do the implantation 
in the EP Lab was $14,230.44 ($225.88 x 63 cases).  
The total labor cost to do 63 ILRs in CVCU was 
$5,297.04 ($84.08 x 63 cases).  This would result in a 
cost saving of $8,883.00. 
The charge for performing an ILR was estimated 
at $6,280.  Therefore, the 63 cases done in the EP Lab 
over ten months generated revenue of $395,640, 
whereas the 131 cases in CVCU generated revenue of 
$822,680.  There were 68 (131-63) more cases per-
formed at the bedside with an increase in revenue of 
$427,040 (68 cases x $6280). 
DISCUSSION 
The purpose of this study was to compare the prac-
tice of implanting loop recorders at the bedside to im-
plantations in the EP Lab. Findings from this study 
show that insertion of ILRs at the bedside can be done 
faster and with less staff compared to doing the same 
procedure in the EP Lab. These results are congruent 
with Kanters et al. (2016), who found that the ILRs can 
be implanted in areas other than the catheterization 
laboratory with less staff and equipment.  While im-
planting the ILR in the patients’ rooms, the EP Lab can 
be reserved for more invasive procedures. Thus, pa-
tients, who need to undergo more complex procedures 
would have to wait less for the EP Lab.  Kipp et al. 
(2017) stated that implanting ILRs in a non-surgical 
location facilitated physicians’ daily workflow and 
availability of clinical staff. Nguyen et al. (2017) indi-
cated that implanting ILRs in an outpatient site allo-
cates time and resources for costly and complex proce-
dures, improving in-hospital productivity and ROI.     
       Overall, an EP physician will have less delay be-
tween patients since the patient is already in a hospital 
room. There is no delay waiting for the EP lab to be 
cleaned and prepared between patients. Additionally, 
the same staff will conduct pre and post procedure 
care, reducing the number of staff needed for the pro-
cedure.  Kanters et al. (2015) reported that changing 
the setting of the implantation and practice efficiencies 
resulted in cost savings in hospitals in the Netherlands, 
France, and the United Kingdom. 
 Patients’ average LOS decreased since there was 
no need for post-sedation monitoring post procedure.  
The electrophysiologist inserts the ILRs using a local 
anesthetic agent and no intravenous anesthetic agents 
are administered.  This finding is in agreement with 
Wong et al. (2016) who mentioned that using only a 
local anesthetic agent during implantation resulted in 
patients being discharged home sooner.  Additionally, 
researchers have found that patients who undergo ILR 
implantation with local anesthesia experience in-
creased satisfaction and well-being (Leahy & Daven-
port, 2015).  Patients could fulfill routine activities of 
daily living, as tolerated, after the procedure (Leahy & 
Davenport, 2015).  Also, implanting ILRs at the bed-
side vs. the EP lab decreases patients’ length of stay 
and subsequently improve patient satisfaction (Ngu-
yen et al., 2017; Steffel, Wright, Scha¨fer, Rashid-
Table 2 
 
Labor Charges in the EP Lab vs CVCU  
  
Procedure in EP Lab       Procedure at Bedside     
  
EP RN CVCU RN 
EP  
Tech 
Total 
charges 
CVCU 
RN 
EP 
Tech Total Charges 
Salary per hour ($) 51.36 45.00 39.08   45.00 39.08   
FTEs 2 1 2   1 1   
Total Cost per hour 102.72 45.00 78.16 225.88 45.00 39.08 84.08 
Note. EP: Electrophysiology, CVCU: Cardiac and Vascular Unit, FTEs= Full Time Equivalent staff 
Table 3 
 
Labor Charges in 15 Minute Increments per Procedure  
  Procedures in 
EP Lab 
Procedures in 
CVCU 
Total  
Charges per 
Hour ($) 
225.88 84.08 
Charges  per 
15 minutes 
($) 
56.47 21.02 
Note. EP: Electrophysiology, CVCU: Cardiac and Vascular Unit  
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Fadel, & Lewalter, 2017).  
Some studies have shown that ILRs can be safely 
implanted at the bedside (Kipp et al., 2017; Wong et 
al., 2016; Mittal et al., 2015; Pachulski et al., 2013, 
Suneet et al., 2015). The new knowledge generated by 
findings from the current study may prove beneficial to 
health care providers, patients, and hospitals.  The in-
sertion of ILRs in CVCU resulted in decreased cost, 
patients’ LOS, number of staff involved, and increased 
number of procedures and revenue. Health care leaders 
may consider making ILRs implantation at the bedside 
the new standard of care. 
LIMITATIONS 
The main strength of this study is the cost analysis 
comparison, which has great implications for patients, 
physicians, hospitals, health insurances, and the 
healthcare system in general.  However, a limitation 
was that a comparison of adverse events following the 
procedure was not done.  Since patients were given the 
usual post-surgery discharge instructions informing 
them to look for signs/symptoms of infection and fol-
low-up appointments with their physicians, hospital 
medical charts did not contain follow-up information.  
Additionally, a convenience sample of medical charts 
was used for this research.  Nonetheless, a power anal-
ysis showed that 194 medical charts were an adequate 
sample size for this study.  Future studies should ex-
plore patient outcomes of ILR insertion in different 
settings.   
IMPLICATIONS FOR NURSING PRACTICE  
The findings from the present study have several 
of implications for nursing practice and hospital ad-
ministrators.  With new legislation for reimbursements 
tied to patient satisfaction, hospitals are faced with the 
daunting task to implement cost saving and budget-
friendly interventions (Steffel et al., 2017).  Patient 
satisfaction, for example, has been increasingly popu-
lar in influencing reimbursement.  Having the ILR 
implanted at the bedside in a unit such as CVCU in-
stead of the EP Lab can result in quicker discharge 
times and increased patient satisfaction.  
The process for implantation requires less inter-
vention in the unit.  There is no need for the placement 
of an intravenous catheter or the prepping of an entire 
EP suite; therefore, the procedure time is reduced.  
Moreover, patients LOS in the hospital decreases be-
cause recovery with local anesthetics occurs faster.  
The less invasive nature of the procedure combined 
with the decreased LOS can increase patient satisfac-
tion (Steffel et al., 2017). 
The EP Lab is a high revenue generating unit for 
hospitals. Implanting the device at the bedside has 
proven more cost-effective. Performing bedside im-
plantation of ILRs would allow interventional cardiol-
ogists to implant more devices on a daily basis than 
what can be performed in the EP Lab.  The increase in 
implantation procedures, combined with the lower cost 
of performing a bedside procedure, will in turn in-
crease revenue for the hospitals and physicians. Im-
planting ILRs at the bedside is worthwhile (Rogers et 
al., 2014).  
CONCLUSION 
Decreased costs and increased revenues are not the 
only indications for implanting ILRs at the bedside.  
Previous research confirms that bedside implantation 
of ILRs is  safe, and complications are minimal (Sun-
eet et al., 2015). Conducting ILRs at the bedside would 
reduce the amount of time between room cleanings.  
This results in increased patient volume, as the facility 
is able to accommodate more cases and generate more 
revenue. With the improved efficiency of bedside in-
sertion of ILRs, compared to the same procedures done 
in an EP lab, bedside insertion may soon become the 
standard of care for patients requiring long term cardi-
ac monitoring.  
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